Funding Received
$63 Million in 6 Rounds from 8 Investors
Most Recent Funding
$3 Million Series D on October 15, 2012
Founded:
2006
Headquarters:
Lexington, MA
Description:
Promedior is a biopharmaceutical company developing novel therapeutics for the treatment of inflammatory and fibrotic diseases.
Founders:
Jim Broderick
Categories:
Biotechnology
Website:
http://promedior.com

Detailed Description

Update

Promedior is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of inflammatory and fibrotic diseases

Promedior has developed a novel drug discovery platform to regulate the monocyte-derived cell populations that play key roles in fibrotic, inflammatory and autoimmune diseases. By specifically targeting these cells at the site of injury, Promedior is able to treat the source of aberrant immune system responses, promote tissue healing and resolution, and greatly reduce the risk of systemic side effects inherent in current therapeutic approaches.

Promedior is developing drugs to address the most severe and difficult-to-treat fibrotic and inflammatory conditions of the eye, lung and kidney such as glaucoma, age-related macular degeneration, diabetic retinopathy and dry eye disease; pulmonary fibrosis, scleroderma and COPD; and acute and chronic nephropathy.

Current Team (6)

Update

Past Team (1)

Update

Board Members and Advisors (7)

Update

Investors (8)

Update

Offices/Locations (1)

Update
  • HQ

    101 Hartwell Avenue

    Lexington, MA 02421

    USA

Images (1)

Update
  • C892f8d1ab59318d819a9de842b0e814